{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Waco",
      "state": "TX",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "74126",
      "recalling_firm": "Allergan Sales, LLC",
      "address_1": "8301 Mars Dr",
      "address_2": "N/A",
      "postal_code": "76712-6578",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "recall_number": "D-1065-2016",
      "product_description": "Tazorac (tazarotene) Gel 0.05%, 15 x 3.5g,  sample packs, Allergan Inc, Irvine, CA 92612. UPC 300238335159",
      "product_quantity": "N/A",
      "reason_for_recall": "Failed Content Uniformity Specifications.",
      "recall_initiation_date": "20160510",
      "center_classification_date": "20160706",
      "termination_date": "20171206",
      "report_date": "20160713",
      "code_info": "Lot #: 84126, Exp FEB/2017"
    }
  ]
}